Understanding access to novel high-cost cancer therapies across Canada: a national survey of pediatric oncology providers

• by Kriti Kumar, Avram Denburg, Celine Cressman, Derek S. Tsang, Marcel Romanick, Myanca Rodrigues, Paul J. Gibson

• May 20, 2026

Rethinking Progress in Clinical Trials

Three clinical development leaders discuss how early signals, trial design, regulatory expectations, and patient access are reshaping clinical development

• May 20, 2026

• 11 min

Roswell Park Experts Report on Discovery of Rare Bladder Cells, Neural Mapping of Pelvic Floor Muscles at AUA 2026

Evidence provided by a Roswell Park study indicates that neoadjuvant chemotherapy may be the preferred course of treatment for patients with non-muscle-invasive bladder cancer (NMIBC) when their disease progresses and they are diagnosed with muscle-invasive bladder cancer (MIBC)

• by

• May 19, 2026

• 7 min

This Week’s Biopharma News: FDA Commissioner Steps Down

Marty Makary’s resignation puts the agency under acting leadership, while BMS and Hengrui unveil a multibillion-dollar pipeline deal and GSK lines up a chronic hepatitis B launch in China.

• May 19, 2026

• 4 min